Navigation Links
Synaptics to Showcase Industry-Leading Human Interface Solutions At 2014 Consumer Electronics Show
Date:1/2/2014

LAS VEGAS, Jan. 2, 2014 /PRNewswire/ -- Synaptics Inc. (NASDAQ: SYNA), a leading developer of human interface solutions, today announced it will showcase several milestone innovations at the 2014 Consumer Electronics Show (CES) in Las Vegas from January 7th through January 10th. On the heels of a banner year for human interface advancement, the company will highlight several industry-first solutions to commercially debut in 2013 while also providing visitors with a glimpse into the future of human interface technology.

Human Interface Innovation Today – Major Milestones of 2013

  • ClearPad® 3350: The industry's first full High-Definition (HD) In-Cell touchscreen is powered by the ClearPad 3350 single-chip touch controller solution, which integrates touch directly in the display, delivering Nexus 5 users best-in-class touch sensitivity and a 10-finger multi-touch experience.
  • ClearPad® Single-Layer On-Cell (SLOC): The ClearPad SLOC solution is the first to fuse the touch sensor and liquid crystal display (LCD) together into one sleek stack-up, enabling thinner, lighter smartphone designs that became commercially available for the first time in 2013 via the Moto G and Yulong's Coolpad, entry-level 8908 smartphone for the China market.
  • 3D-Touch™: Powering the Samsung Galaxy S4 in 2013 as AirView™, this gesture technology expands user interface possibilities with proximity, finger hover and air swipe functionality.
  • TypeGuard™: TypeGuard software technology virtually eliminates false cursor movements, accidental taps and false edge scrolls by differentiating between a finger and a palm, giving users a more a
    '/>"/>

SOURCE Synaptics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. First international collaboration to showcase latest body of evidence of dairy health benefits
2. Drive-Up Biometric System from SRI International Sarnoff Wins New Product Showcase Award at ISC West 2013
3. ValidSoft Showcases SMART at Finovate Fall, NYC
4. Special issue of Botany showcases CANPOLIN research
5. 2 NASA visualizations selected for computers graphics showcase
6. Gene therapy for human skin disease produces long-term benefits
7. Walking the walk: What sharks, honeybees and humans have in common
8. Study led by NUS scientists provides new insights into cause of human neurodegenerative disease
9. UCLA stem cell scientists first to track joint cartilage development in humans
10. Not all species age the same; humans may be outliers
11. Study finds biomaterials repair human heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2015)... Mar. 11, 2015 Research and Markets ... "Access Control Market by Product, Application & By ... report to their offering. , This report ... reach $10.4 billion by 2020, with an estimated CAGR ... covers the products types such as contact cards & ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
(Date:3/10/2015)... , March 10, 2015   Tute Genomics ... has been selected by next-generation sequencing company PrimBio ... whole exome and targeted gene panel interpretation. ... has adopted the most current technologies to support the ... research. The company offers two types of exome sequencing ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... West Nile fever, dengue fever, and chikungunya fever spread rapidly ... understand the mosquito,s immune system and how the viral pathogens ... be transmitted to human and animal hosts. In ... high levels of morbidity and mortality after being bitten by ...
... NY The Damon Runyon Cancer Research Foundation, ... career researchers, named 18 new Damon Runyon Fellows ... The recipients of this prestigious, three-year award are ... research in the laboratories of leading senior investigators ...
... -- Honing chemotherapy delivery to cancer cells is a ... take the chemotherapy "bait" is a greater challenge. But ... greater success than by the nanotechnology research team of ... of Anesthesiology Perioperative and Pain Medicine and Research. ...
Cached Biology News:Researchers discover novel anti-viral immune pathway in the mosquito 2Damon Runyon grants Fellowship and Breakthrough Scientist awards to 21 top young scientists 2Damon Runyon grants Fellowship and Breakthrough Scientist awards to 21 top young scientists 3Damon Runyon grants Fellowship and Breakthrough Scientist awards to 21 top young scientists 4Damon Runyon grants Fellowship and Breakthrough Scientist awards to 21 top young scientists 5Damon Runyon grants Fellowship and Breakthrough Scientist awards to 21 top young scientists 6Damon Runyon grants Fellowship and Breakthrough Scientist awards to 21 top young scientists 7Damon Runyon grants Fellowship and Breakthrough Scientist awards to 21 top young scientists 8Getting cancer cells to swallow poison 2
(Date:3/31/2015)... MONMOUTH JUNCTION, N.J., March 31, 2015 ... immunotherapy company using blood purification to treat critically-ill ... provides an operational summary and reports financial results ... 2014 CytoSorb® product revenues were ... 281%, compared to 2013 CytoSorb® revenues of $0.8M ...
(Date:3/31/2015)... March 31, 2015 Pittcon 2015, the ... Spectroscopy, ended on March 12, in New Orleans with ... million as estimated by the New Orleans Convention and ... 14,200 conferees and exhibitor personnel. Those who attended ... conferee number. For the third year, the co-location of ...
(Date:3/31/2015)... YORK , March 31, 2015  PlasmaTech ... company advancing protein biologic therapies and oncology supportive ... partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: 128940) ... country,s Ministry of Food and Drug Safety ("MFDS") ... for MuGard, its oncology supportive-care treatment for the ...
(Date:3/31/2015)... March 31, 2015 Lighthouse Information ... with operations in California, Oregon, Washington and clients ... its Merger and Acquisition (M&A) Integration Services offering, ... VP Client Services and M&A Integration Practice Leader ... the vast majority of M&A initiatives fail to ...
Breaking Biology Technology:CytoSorbents Reports Record 2014 Revenue 2CytoSorbents Reports Record 2014 Revenue 3CytoSorbents Reports Record 2014 Revenue 4CytoSorbents Reports Record 2014 Revenue 5CytoSorbents Reports Record 2014 Revenue 6CytoSorbents Reports Record 2014 Revenue 7CytoSorbents Reports Record 2014 Revenue 8CytoSorbents Reports Record 2014 Revenue 9CytoSorbents Reports Record 2014 Revenue 10CytoSorbents Reports Record 2014 Revenue 11Pittcon 2015 Hits the Big Easy in a Big Way 2Pittcon 2015 Hits the Big Easy in a Big Way 3Pittcon 2015 Hits the Big Easy in a Big Way 4PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Lighthouse Information Systems, Inc., Announces Addition of M&A Integration Services 2
... Inc.,(NYSE: FRX ) and Mylan Inc. (NYSE: ... (nebivolol) was approved by the U.S. Food and Drug,Administration ... once,daily medication that can be used alone or in ... in the U.S. and 65 percent of patients diagnosed ...
... regulatory authorities support filing strategy, SEATTLE, Dec. ... CTIC) reported today that it met with and ... marketing,authorization application (MAA) for XYOTAX(TM) (paclitaxel poliglumex,CT-2103). The ... first quarter,of 2008, earlier than the first half ...
... N.Y. - A new biochip technology could eliminate animal ... curtail its use in the development of new pharmaceuticals, ... at Rensselaer Polytechnic Institute, the University of California at ... most recent discovery will be featured in the online ...
Cached Biology Technology:Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension 2Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension 3Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension 4Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension 5Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule 2Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule 3Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule 4Biochip mimics the body to reveal toxicity of industrial compounds 2Biochip mimics the body to reveal toxicity of industrial compounds 3
... Buffers are membrane-filtered isotonic and enzyme-free ... and cell-conditioning agents in either Ca2+- ... or Ca2+- and Mg2+-free phosphate-buffered ... cells from support substrates and each ...
Goat polyclonal to PINX1 ( Abpromise for all tested applications). entrezGeneID: 54984 SwissProtID: Q548A5...
...
... Kit Components , 25 g Blocking Reagent , ... 10 ml T7 Elution Buffer , 0.2 ml ... , 0.2 ml BLT5615 glycerol stock , 1010 ... Negative Control Lysate , 50 l S-protein HRP Conjugate ...
Biology Products: